North Rhine-Westphalia is one of the first German states to publish a key issues paper on a knowledge-based bioeconomy strategy. Thereby North Rhine-Westphalia is one of the first regions in Europe to extend the definition of the bioeconomy to include the health sector and, in particular, pharmaceutical biotechnology, also known as red biotechnology. NRW places particular emphasis on the life science sector of the state and on biotechnological innovations.